Logotype for Teladoc Health Inc

Teladoc Health (TDOC) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Teladoc Health Inc

Q1 2026 earnings summary

30 Apr, 2026

Executive summary

  • Q1 2026 consolidated revenue reached $614 million, with Adjusted EBITDA of $58.2 million, both exceeding guidance midpoints, reflecting strong Integrated Care performance and progress in scaling insurance at BetterHelp.

  • First quarter revenue was down 2% year-over-year, with net loss narrowing to $63.8 million from $93.0 million in the prior year.

  • Integrated Care revenue grew 1.5% YoY to $395 million, while BetterHelp revenue declined 9% YoY due to cash pay pressure, partially offset by insurance revenue growth.

  • Strategic focus on product innovation, AI integration, and expanding insurance coverage in BetterHelp, now live in 30 states and DC with over 6,000 credentialed providers.

  • Operational excellence and cost discipline remain priorities, with AI-driven efficiencies and a strong balance sheet supporting ongoing investments.

Financial highlights

  • Q1 2026 consolidated revenue: $614 million; Adjusted EBITDA: $58.2 million (9.5% margin), both exceeding guidance midpoints.

  • Net loss per share: $0.36, including $0.50 amortization, $0.08 stock-based compensation, and $0.07 restructuring costs per share.

  • Free cash flow: net outflow of $26.3 million; cash and equivalents: $751 million; net debt to trailing Adjusted EBITDA: under 0.9x.

  • U.S. revenue decreased 6% to $491.5 million; international revenue increased 17% to $122.3 million.

  • Integrated Care Adjusted EBITDA: $56 million (14.2% margin, up 130 bps YoY); BetterHelp Adjusted EBITDA: $2 million (0.9% margin, down from 3.2% YoY).

Outlook and guidance

  • 2026 consolidated revenue guidance: $2.48–$2.58 billion; Adjusted EBITDA: $267–$306 million; free cash flow: $130–$170 million.

  • Full-year net loss per share projected at $1.05–$0.75; stock-based compensation expected below $55 million (down 30% YoY).

  • Q2 2026 revenue guidance: $597–$626 million; Adjusted EBITDA: $55–$67 million.

  • Integrated Care 2026 Adjusted EBITDA margin guidance: 15.1%–16.1%; BetterHelp revenue guidance narrowed to down 6.5% to down 1.0% YoY, with insurance revenue expected at $90–$105 million.

  • Integrated Care segment revenue growth expected at 0.8%–3.5% for the year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more